<div id="readability-page-1">Oklo Inc. (NYSE:OKLO - Get Free Report) was down 3.1% on Friday after UBS Group lowered their price target on the stock from $95.00 to $60.00. UBS Group currently has a neutral rating on the stock. Oklo traded as low as $50.15 and last traded at $50.2210. Approximately 6,327,169 shares were traded during trading, a decline of 39% from the average daily volume of 10,454,525 shares. The stock had previously closed at $51.81.<ul><li>MarketBeat Week in Review – 03/16 - 03/20</li></ul>A number of other research analysts have also commented on OKLO. Canaccord Genuity Group decreased their price objective on Oklo from $175.00 to $125.00 and set a &#34;buy&#34; rating on the stock in a report on Wednesday, March 18th. Citigroup reduced their target price on shares of Oklo from $95.00 to $73.50 and set a &#34;neutral&#34; rating for the company in a research report on Wednesday, March 18th. Texas Capital raised shares of Oklo to a &#34;strong-buy&#34; rating in a research report on Tuesday, January 27th. Cantor Fitzgerald reiterated an &#34;overweight&#34; rating and issued a $122.00 price objective on shares of Oklo in a research note on Wednesday, March 18th. Finally, Weiss Ratings restated a &#34;sell (d)&#34; rating on shares of Oklo in a research report on Thursday, January 22nd. Two research analysts have rated the stock with a Strong Buy rating, nine have issued a Buy rating, six have issued a Hold rating and two have issued a Sell rating to the company. According to MarketBeat, the stock has an average rating of &#34;Moderate Buy&#34; and a consensus price target of $84.30.Check Out Our Latest Research Report on Oklo<h2>Insider Activity</h2><ul><li>Oklo: The Bottom Is In, and the Upside Potential Is Nuclear</li></ul>In other news, insider William Carroll Murphy Goodwin sold 2,820 shares of the stock in a transaction on Monday, March 9th. The stock was sold at an average price of $56.69, for a total transaction of $159,865.80. Following the sale, the insider directly owned 15,991 shares of the company's stock, valued at approximately $906,529.79. This represents a 14.99% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Jacob Dewitte sold 72,960 shares of the business's stock in a transaction dated Friday, March 13th. The shares were sold at an average price of $60.00, for a total value of $4,377,600.00. Following the completion of the transaction, the chief executive officer directly owned 751,533 shares of the company's stock, valued at approximately $45,091,980. This trade represents a 8.85% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders sold 1,222,424 shares of company stock worth $100,739,512. 18.90% of the stock is currently owned by company insiders. <h2>Key Stories Impacting Oklo</h2>Here are the key news stories impacting Oklo this week:<ul> <li>Positive Sentiment: Regulatory progress for the Aurora reactor program was reported, suggesting advancement on licensing milestones that de‑risk the company's flagship project and its timeline to commercial revenue. Regulatory progress for Aurora</li> <li>Positive Sentiment: Oklo completed the acquisition of Atomic Alchemy to enter domestic production of medical and industrial isotopes, diversifying revenue potential beyond reactors and shortening a path to cash flow. The company also reiterated reactor progress in the same update. Oklo Acquisition And Reactor Progress Reframe Long Term Investor Debate</li> <li>Positive Sentiment: CEO and co‑founder Jacob DeWitte was appointed to the President’s Council of Advisors on Science and Technology (PCAST), a high‑profile government advisory role that can improve regulatory access and legitimacy for advanced nuclear projects. Oklo Co-Founder and CEO Appointed to Serve on President's Council of Advisors on Science and Technology</li> <li>Neutral Sentiment: Analysts remain conflicted on Oklo alongside other utilities/energy names, reflecting divergent views on commercialization timelines and regulatory risk that increase short‑term volatility. Analysts Conflicted on These Utilities Names: Oklo Inc (OKLO) and PG&amp;E (PCG)</li> <li>Neutral Sentiment: Comparative coverage with peers (e.g., Montauk Renewables) has appeared, useful for investors benchmarking Oklo's valuation and business model but not a direct positive/negative catalyst. Critical Comparison: Montauk Renewables NASDAQ: MNTK and Oklo NYSE: OKLO</li> <li>Negative Sentiment: UBS cut its price target from $95 to $60 and set a &#34;neutral&#34; rating, signaling lower near‑term upside and contributing to selling pressure. Benzinga</li> <li>Negative Sentiment: B. Riley trimmed its price target to $92, another downward analyst revision that likely dampened sentiment despite longer‑term growth narratives. OKLO Price Target Trimmed to $92</li> </ul><h2>Institutional Inflows and Outflows</h2><ul><li>Up 135% in the Past Year, Can Cameco Continue Its Run?</li></ul>Hedge funds have recently added to or reduced their stakes in the company. Hsbc Holdings PLC raised its position in Oklo by 1,184.4% during the fourth quarter. Hsbc Holdings PLC now owns 112,372 shares of the company's stock valued at $8,063,000 after purchasing an additional 103,623 shares in the last quarter. Rockefeller Capital Management L.P. boosted its holdings in shares of Oklo by 427.1% in the 4th quarter. Rockefeller Capital Management L.P. now owns 171,128 shares of the company's stock valued at $12,280,000 after purchasing an additional 138,659 shares in the last quarter. SHP Wealth Management acquired a new stake in shares of Oklo in the 4th quarter valued at $32,000. Tulsa Wealth Advisors INC bought a new position in shares of Oklo in the 4th quarter valued at $332,000. Finally, Strategic Investment Solutions Inc. IL increased its stake in shares of Oklo by 45.5% in the 4th quarter. Strategic Investment Solutions Inc. IL now owns 1,488 shares of the company's stock valued at $107,000 after purchasing an additional 465 shares during the last quarter. 85.03% of the stock is owned by institutional investors. <h2>Oklo Stock Performance</h2>The company has a market cap of $8.72 billion, a price-to-earnings ratio of -69.75 and a beta of 0.80. The business has a fifty day moving average price of $69.01 and a 200 day moving average price of $94.13. Oklo (NYSE:OKLO - Get Free Report) last released its quarterly earnings data on Tuesday, March 17th. The company reported ($0.27) earnings per share for the quarter, missing the consensus estimate of ($0.17) by ($0.10). During the same quarter last year, the business earned ($0.74) earnings per share. As a group, equities analysts anticipate that Oklo Inc. will post -8.2 EPS for the current year. <h2>Oklo Company Profile</h2> (Get Free Report)Oklo, Inc is a California-based energy technology company specializing in the design and development of advanced nuclear microreactors. Headquartered in Fremont, the firm focuses on small modular reactor (SMR) technology that leverages fast-neutron fission and liquid-metal cooling to deliver carbon-free power. Oklo’s core objective is to bring compact, factory-built reactors online within a decade, offering a low-footprint alternative to traditional large nuclear plants. The company’s flagship product, the Aurora microreactor, is a 1.5-megawatt electric (MWe) fast reactor cooled by a sodium alloy.<h2>Featured Stories</h2><ul><li>Five stocks we like better than Oklo</li></ul>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.<h2>Should You Invest $1,000 in Oklo Right Now?</h2>Before you consider Oklo, you'll want to hear this.MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oklo wasn't on the list.While Oklo currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.View The Five Stocks Here </div>

OKLL

OKLO

OKLS

Oklo Inc. (NYSE:OKLO) shares fell 3.1% after UBS Group downgraded its price target from $95 to $60, maintaining a neutral rating. The stock traded as low as $50.15, with a significant drop in trading volume. Other analysts have also adjusted their price targets, with Canaccord Genuity lowering theirs to $125 and Citigroup to $73.50. Insider selling has been noted, with CEO Jacob Dewitte selling 72,960 shares. Despite positive regulatory developments, analysts express mixed sentiments about Oklo's commercialization timelines and regulatory risks.

Oklo (NYSE:OKLO) Shares Down 3.1% Following Analyst Downgrade